Stock listing

TPEx:4167 Savior Lifetec Corp. (松瑞藥) 股價

Follow Savior Lifetec Corp. into a list and get an email when it puts out news.

Share price · TPEX:4167

$15.75 TWD -1.80 (-10.3%)

Close on Nov 20, 2026

Past year -5.5% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$15.75 – $16.85 TWDNov 20, 2026
Volume
2.03M sharesNov 20, 2026
Market cap
$5.22B TWDAt the close on Nov 20, 2026 · price × 331.6M shares outstanding
52-week range
$15.75 – $23.95 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$32.54M TWDMedian day 978,182 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Savior Lifetec Corp. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:4167 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$15.75-1.80-10.3%$16.85$16.85$15.752,034,721
$17.55-0.45-2.5%$18.25$18.25$17.451,548,168
$18.00-0.10-0.6%$17.90$18.10$17.751,431,882
$18.10-1.05-5.5%$19.20$19.20$18.101,425,007
$19.15+0.15+0.8%$19.20$19.45$19.05983,583
$19.00-0.25-1.3%$19.30$19.35$18.90943,045
$19.25+0.25+1.3%$19.10$19.35$18.751,173,949
$19.00+0.05+0.3%$19.05$19.35$18.801,027,237
$18.95+0.55+3.0%$18.90$19.35$18.601,241,102
$18.40-0.50-2.6%$17.55$18.65$17.552,100,188
$18.90-0.65-3.3%$19.50$19.80$18.751,769,596
$19.55+0.05+0.3%$19.50$19.65$19.101,001,910
$19.50-0.45-2.3%$19.85$20.05$19.451,429,062
$19.95-0.15-0.7%$19.95$20.10$19.90790,583
$20.10-0.30-1.5%$20.30$20.30$20.001,300,460
$20.40-0.10-0.5%$20.50$20.55$20.20898,573
$20.50-0.10-0.5%$20.60$20.70$20.301,045,889
$20.60-0.30-1.4%$20.90$21.25$20.551,776,089
$20.900.000.0%$20.90$20.90$20.900
$20.900.000.0%$20.80$20.95$20.751,046,905
$20.90+0.15+0.7%$20.75$21.05$20.651,216,627
$20.75+0.10+0.5%$20.65$20.80$20.501,385,531
$20.65-1.15-5.3%$21.80$21.80$20.453,279,242
$21.80+0.05+0.2%$21.75$22.10$21.651,285,266
$21.75-0.40-1.8%$21.85$22.45$21.602,779,456
$22.15-0.25-1.1%$22.50$22.50$22.004,101,642
$22.40+0.75+3.5%$21.25$22.45$21.206,548,744
$21.65-0.35-1.6%$23.30$23.95$21.4013,148,541
$22.00+1.55+7.6%$20.95$22.40$20.959,651,254
$20.45+1.00+5.1%$19.45$20.85$19.454,548,594
$19.450.000.0%$19.45$19.65$19.40563,232
$19.45-0.10-0.5%$19.60$19.65$19.35453,773
$19.55-0.05-0.3%$19.60$19.60$19.40576,391
$19.60-0.25-1.3%$19.80$19.95$19.55470,993
$19.85+0.30+1.5%$19.65$19.90$19.45848,882
$19.55+0.15+0.8%$19.50$19.60$19.40536,088
$19.40-0.30-1.5%$19.70$19.70$19.30597,411
$19.70-0.05-0.3%$19.80$19.90$19.70630,159
$19.75+0.10+0.5%$19.50$19.80$19.50699,811
$19.650.000.0%$19.35$19.70$19.35517,741
$19.65+0.15+0.8%$19.45$19.65$19.20994,557
$19.50+0.40+2.1%$19.10$19.55$19.001,148,166
$19.10+0.05+0.3%$19.20$19.20$19.05420,343
$19.05+0.20+1.1%$18.90$19.20$18.90362,488
$18.85-0.10-0.5%$18.85$19.00$18.70457,032
$18.95-0.15-0.8%$19.00$19.05$18.90477,049
$19.100.000.0%$19.05$19.15$19.00533,932
$19.10+0.20+1.1%$19.05$19.20$18.95865,863
$18.900.000.0%$18.95$19.15$18.80504,550
$18.90-0.25-1.3%$19.20$19.20$18.80544,604
$19.15+0.15+0.8%$19.05$19.25$18.80854,216
$19.00-0.35-1.8%$19.50$19.50$19.00912,438
$19.35-0.15-0.8%$19.50$19.55$19.30451,384
$19.50-0.25-1.3%$19.65$19.85$19.40902,653
$19.75-0.25-1.3%$20.10$20.10$19.60972,780
$20.00-0.15-0.7%$20.55$20.55$19.95619,357
$20.15-0.10-0.5%$20.25$20.25$20.10581,040
$20.250.000.0%$20.30$20.50$20.15586,320
$20.25-0.15-0.7%$20.45$20.65$20.25840,449
$20.40-0.55-2.6%$20.85$21.10$20.351,191,258
$20.95+0.25+1.2%$20.70$21.20$20.502,234,950
$20.70+0.85+4.3%$19.95$21.00$19.953,210,372

Splits

2 splits since 2021 · TPEX:4167 · every price before a split is adjusted for it

DayRatioWhat
1.068-for-1Split
99-for-94Split
Ticker
TPEx:4167
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
TPEx
Currency
TWD

Latest news

All Savior Lifetec Corp. news

Savior Lifetec Corp. on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
16 in all · newest Aug 5, 2022 · oldest 2022
Decks
4 decks · latest Nov 22, 2023

Valuation

P/E 5.1× against a median of 30.6×: the lowest of 10 Pharmaceuticals companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$2.50B TWD
P/E
5.1×
EV/sales
2.2×
EV/EBITDA
12.1×
Price/book
1.2×
Gross margin
33.4%
Operating margin
11.1%
Net margin
91.9%
Debt to equity
0.0×
Beta
No index for this market yet

Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Savior Lifetec Corp. · TPEX:4167US$158.4MUS$75.85M5.1×2.2×12.1×1.2×91.9%0.0×n/a
CF PharmTech. Inc. Class H · HKEX:2652US$173.6MUS$114.7M466×1.8×12.4×0.9×0.6%0.1×n/a
SIGA Technologies Inc. · NASDAQ:SIGAUS$172.5MUS$56.35M251×1.1×n/a1.1×1.3%0.0×1.01
Searle Company Ltd · PSX:SEARLUS$169.6MUS$163.7M68.6×1.2×6.4×1.4×1.8%0.0×n/a
Dawnrays Pharmaceutical Holdings Ltd. · HKEX:2348US$165.1M−US$72.72M5.2×−0.4×−1.4×0.3×17.4%0.0×n/a
SCI Pharmtech Corp. · TWSE:4119US$164.3MUS$193.9M90.0×5.1×17.8×1.0×4.8%0.2×n/a
Binh Dinh Pharmaceutical & Medical Equipment JSC · HOSE:DBDUS$161.0MUS$149.0M13.2×2.0×10.5×2.3×16.6%0.1×n/a
AGP Limited · PSX:AGPUS$153.6MUS$167.2M12.0×1.7×6.0×2.8×13.4%0.3×n/a
Whan In Pharmaceutical Co., Ltd. · KRX:016580US$151.2MUS$101.3M9.9×0.5×4.2×0.5×7.5%0.0×n/a
Jagsonpal Pharmaceuticals Ltd. · NSE:JAGSNPHARMUS$149.2MUS$127.4M30.6×3.7×19.2×5.8×14.3%0.0×n/a
Vivozon Pharmaceutical Co., Ltd. · KRX:082800US$147.5MUS$139.5Mn/a3.7×n/a2.1×−65.2%0.0×n/a
Median of the othersUS$162.6MUS$133.4M30.6×1.8×8.4×1.2×6.1%0.0×1.01

Events

QuarterResultsShare move
Q4 2022Mar 2, 2023 · After close+1.4%
Q3 2022Nov 10, 2022 · Before open+0.6%
Q1 2022May 5, 2022 · After close−2.8%
Q4 2021Mar 20, 2022 · After close+3.4%
Q3 2021Nov 3, 2021 · After close+2.2%
Quarter to Jun 30, 2021Aug 5, 2021 · After close−0.6%
Quarter to Mar 31, 2021May 13, 2021 · After close+3.1%
Quarter to Dec 31, 2020Mar 18, 2021 · After close+3.4%

Open Events

Decks

DeckKindSlidesDate
9M23 Earnings PresentationEarnings22 slidesNov 22, 2023
Q3 2023 Earnings PresentationEarnings22 slidesNov 22, 2023
Q3 2022 Earnings PresentationEarnings24 slidesNov 10, 2022
Q3 2022 Earnings PresentationEarnings24 slidesNov 10, 2022

Open Decks

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue1.20B1.22B1.05B1.27B1.74B1.83B1.32B1.10B1.62B1.53B
Cost of revenue778.3M870.6M829.3M1.13B1.44B1.27B967.7M1.18B1.18B1.35B
Gross profit423.4M346.8M220.9M131.0M307.9M558.6M351.0M-70.5M440.3M186.9M
Research and development67.2M75.1M111.0M119.1M167.3M179.1M187.7M142.8M215.8M242.7M
Selling, general and administrative158.0M152.7M76.1M76.3M79.7M97.5M72.8M73.5M68.3M65.5M
Operating income198.2M118.9M-2.42M52.0M24.7M287.0M34.2M-357.8M106.0M-183.1M
Depreciation and amortization92.1M127.0M182.2M208.7M238.7M221.6M213.3M206.5M202.8M207.3M
EBITDA290.3M245.9M179.7M260.7M263.3M508.7M247.5M-151.3M308.8M24.3M
Interest expense5.43M7.48M9.87M15.7M17.9M24.2M31.9M17.5M26.9M35.9M
Income before tax534.1M179.4M27.5M36.3M9.96M250.9M-4.93M-359.5M22.3M-207.7M
Income tax42.0K15.7M14.7M36.1M39.1M15.8M-56.8M11.3M
Net income537.4M182.4M30.0M20.6M-4.76M250.9M-44.0M-359.5M22.3M-207.7M
Earnings per share, basic1.620.540.090.07-0.010.75-0.16-1.380.09-0.84

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents823.4M1.36B1.08B1.09B491.4M682.6M559.0M384.0M674.0M476.6M
Short-term investments789.0M761.1M254.3M563.8M15.7M119.6M24.1M77.4M420.0K
Receivables286.0M239.8M342.6M410.0M1.09B671.5M294.2M190.1M309.5M337.7M
Inventory573.4M670.8M860.0M1.04B1.31B1.08B849.7M1.01B788.3M681.9M
Current assets2.56B3.25B2.55B3.10B2.91B2.55B1.73B1.67B2.06B1.53B
Property, plant and equipment1.27B1.59B2.25B2.28B1.85B1.86B1.89B
Total assets4.18B4.38B3.82B4.41B4.54B4.84B4.03B3.53B3.95B3.44B
Accounts payable45.3M42.2M54.2M69.8M43.2M115.6M27.2M122.9M169.8M133.8M
Current liabilities231.2M690.4M200.9M778.5M298.3M570.8M1.31B875.4M929.7M738.8M
Long-term debt0523.7M520.9M93.3M798.1M854.9M578.7M
Total debt270.4M803.3M951.3M959.0M1.45B1.10B944.9M670.5M
Total liabilities403.3M860.0M458.0M1.04B1.23B1.51B1.82B1.67B1.78B1.32B
Shareholders' equity3.78B3.51B3.35B3.35B3.31B3.33B2.21B1.86B2.16B2.12B
Shares outstanding331.6M339.0M338.6M317.1M317.5M336.7M271.3M260.3M260.1M247.5M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-21.0M518.4M388.0M581.8M-168.3M91.3M156.4M-189.8M260.9M-76.1M
Capital spending-143.2M-118.5M-17.9M-34.2M-95.6M-216.5M-199.3M-204.7M-131.9M-78.0M
Free cash flow-164.3M399.9M370.1M547.6M-263.9M-125.3M-42.9M-394.5M129.0M-154.1M
Cash from investing20.3M18.5M-311.8M-145.8M-2.43M-384.9M-72.2M
Cash from financing-572.2M-7.48M-41.4M344.1M164.4M-97.8M321.5M346.7M
Dividends paid-127.0M-27.0M-32.7M-40.0M-40.0M-40.0M-40.0M
Share buybacks-138.6M019.1M-495.0K-985.0K-490.0K-1.17M
Change in cash-534.7M275.1M-3.07M594.6M-191.2M123.6M175.0M-290.0M197.4M198.5M

Open Financials

Cap table

Built by 6ix from Savior Lifetec Corp.’s releases

Common shares
331,554,306
Fully diluted
331,554,306

Fully diluted

LineShares
Common shares331,554,306

Share count over time

CountShares
Nov 22, 2026331,554,306

Open Cap table

Shareholders

Register

HolderSharesOf the companyAs of
英屬蓋曼群島商sfsventureltd.7.9M2.4%Oct 31, 2026
敏駒投資股份有限公司6.67M2.0%Oct 31, 2026
佳駒投資有限公司4.69M1.4%Oct 31, 2026
漢友財務管理顧問股份有限公司3.92M1.2%Oct 31, 2026
陳勇發685K0.21%Oct 31, 2026
李香雲339K0.10%Oct 31, 2026
張日炎303K0.09%Oct 31, 2026
陳志芳91,6880.03%Oct 31, 2026
林彥嵐80,8560.02%Oct 31, 2026
周家駒66,6900.02%Oct 31, 2026
All 18 holders
HolderSharesOf the companyAs of
陳逸修10,680<0.01%Oct 31, 2026
陳銘輝8,544<0.01%Oct 31, 2026
林國瑋8,544<0.01%Oct 31, 2026
謝榮盛00.00%Oct 31, 2026
林志明00.00%Oct 31, 2026
鍾信勇00.00%Oct 31, 2026
鄭欽華00.00%Oct 31, 2026
王柏森00.00%Oct 31, 2026

Funds

HolderSharesValueAs of
Vanguard Total International Stock Index Fund4.1MUS$2.14MJul 31, 2026
Vanguard Emerging Markets Stock Index Fund3.35MUS$1.75MJul 31, 2026
Emerging Markets Core Equity 2 Portfolio1.51MUS$785KJul 31, 2026
Vanguard Ftse All-World Ex-Us Small-Cap Index Fund1.05MUS$545KJul 31, 2026
Dimensional Emerging Markets Value Fund771KUS$402KJul 31, 2026
The Emerging Markets Small Cap Series615KUS$321KJul 31, 2026
Dimensional Emerging Markets Core Equity 2 ETF386KUS$202KJul 31, 2026
Dimensional Emerging Core Equity Market ETF303KUS$159KJul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF221KUS$115KJul 31, 2026
Vanguard Total World Stock Index Fund194KUS$101KJul 31, 2026
All 22 holders
HolderSharesValueAs of
State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF155KUS$99,180Jun 30, 2026
Avantis Emerging Markets Equity ETF149KUS$93,574May 31, 2026
Dimensional Emerging Markets Value ETF123KUS$64,224Jul 31, 2026
Emerging Markets ex China Core Equity Portfolio111KUS$57,893Jul 31, 2026
Emerging Markets Social Core Equity Portfolio90,189US$47,009Jul 31, 2026
World ex U.S. Core Equity Portfolio76,975US$40,121Jul 31, 2026
World ex U.S. Targeted Value Portfolio61,944US$32,287Jul 31, 2026
Vanguard ESG International Stock ETF59,436US$37,327May 31, 2026
Dimensional Emerging Markets ex China Core Equity ETF32,244US$16,861Jul 31, 2026
Avantis Emerging Markets Small Cap Equity ETF26,000US$16,328May 31, 2026
Avantis Responsible Emerging Markets Equity ETF5,000US$3,140May 31, 2026
Avantis Emerging Markets ex-China Equity ETF1,000US$628May 31, 2026

Open Shareholders

Log in to ask 6ix AI your own questions about Savior Lifetec Corp.